These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17255358)

  • 21. Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patients.
    Niitsu N; Okamoto M; Nakamura N; Nakamine H; Aoki S; Hirano M; Miura I
    Leuk Res; 2007 Sep; 31(9):1191-7. PubMed ID: 17197022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: correlation with clinical outcome.
    Lossos IS; Natkunam Y; Levy R; Lopez CD
    Leuk Lymphoma; 2002 Dec; 43(12):2309-17. PubMed ID: 12613517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes.
    Lossos IS; Czerwinski DK; Alizadeh AA; Wechser MA; Tibshirani R; Botstein D; Levy R
    N Engl J Med; 2004 Apr; 350(18):1828-37. PubMed ID: 15115829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression analysis in aggressive NHL.
    Chan WC; Huang JZ
    Ann Hematol; 2001; 80 Suppl 3():B38-41. PubMed ID: 11757704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular diagnosis and outcome prediction in diffuse large B-cell lymphoma and other subtypes of lymphoma.
    Dybkaer K; Iqbal J; Zhou G; Chan WC
    Clin Lymphoma; 2004 Jun; 5(1):19-28. PubMed ID: 15245604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
    Tsuyama N; Ennishi D; Yokoyama M; Baba S; Asaka R; Mishima Y; Terui Y; Hatake K; Takeuchi K
    Oncotarget; 2017 May; 8(20):33487-33500. PubMed ID: 28380441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures.
    Mahadevan D; Spier C; Della Croce K; Miller S; George B; Riley C; Warner S; Grogan TM; Miller TP
    Mol Cancer Ther; 2005 Dec; 4(12):1867-79. PubMed ID: 16373702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of MZB1 predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature.
    Herold T; Mulaw MA; Jurinovic V; Seiler T; Metzeler KH; Dufour A; Schneider S; Kakadia PM; Spiekermann K; Mansmann U; Hiddemann W; Buske C; Dreyling M; Bohlander SK
    Leuk Lymphoma; 2013 Aug; 54(8):1652-7. PubMed ID: 23189934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of Toll-like receptors in follicular lymphoma, diffuse large B-cell lymphoma and peripheral T-cell lymphoma.
    Smith TJ; Yamamoto K; Kurata M; Yukimori A; Suzuki S; Umeda S; Sugawara E; Kojima Y; Sawabe M; Nakagawa Y; Suzuki K; Crawley JT; Kitagawa M
    Exp Mol Pathol; 2010 Dec; 89(3):284-90. PubMed ID: 20800061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression profiling analysis of the CD5+ diffuse large B-cell lymphoma subgroup: development of a CD5 signature.
    Suguro M; Tagawa H; Kagami Y; Okamoto M; Ohshima K; Shiku H; Morishima Y; Nakamura S; Seto M
    Cancer Sci; 2006 Sep; 97(9):868-74. PubMed ID: 16856881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High level of glutathione-S-transferase pi expression in mantle cell lymphomas.
    Bennaceur-Griscelli A; Bosq J; Koscielny S; Lefrère F; Turhan A; Brousse N; Hermine O; Ribrag V
    Clin Cancer Res; 2004 May; 10(9):3029-34. PubMed ID: 15131039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.
    Green MR; Jardine P; Wood P; Wellwood J; Lea RA; Marlton P; Griffiths LR
    BMC Cancer; 2010 May; 10():195. PubMed ID: 20462409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
    Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
    Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.
    Tada K; Kim SW; Asakura Y; Hiramoto N; Yakushijin K; Kurosawa S; Tajima K; Mori S; Heike Y; Tanosaki R; Maeshima AM; Taniguchi H; Furuta K; Kagami Y; Matsuno Y; Tobinai K; Takaue Y; Fukuda T
    Am J Hematol; 2012 Aug; 87(8):770-5. PubMed ID: 22641292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.
    Wang SS; Maurer MJ; Morton LM; Habermann TM; Davis S; Cozen W; Lynch CF; Severson RK; Rothman N; Chanock SJ; Hartge P; Cerhan JR
    Leukemia; 2009 Mar; 23(3):596-602. PubMed ID: 18830263
    [No Abstract]   [Full Text] [Related]  

  • 36. Gene expression profiling of diffuse large B-cell lymphoma.
    Rosenwald A; Staudt LM
    Leuk Lymphoma; 2003; 44 Suppl 3():S41-7. PubMed ID: 15202524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulation of autophagy in human follicular lymphoma is independent of overexpression of BCL-2.
    McCarthy A; Marzec J; Clear A; Petty RD; Coutinho R; Matthews J; Wilson A; Iqbal S; Calaminici M; Gribben JG; Jia L
    Oncotarget; 2014 Nov; 5(22):11653-68. PubMed ID: 25362242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells.
    Andréasson U; Dictor M; Jerkeman M; Berglund M; Sundström C; Linderoth J; Rosenquist R; Borrebaeck CA; Ek S
    Am J Hematol; 2009 Dec; 84(12):803-8. PubMed ID: 19844990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin D1 expression in B-cell lymphomas.
    Gladkikh A; Potashnikova D; Korneva E; Khudoleeva O; Vorobjev I
    Exp Hematol; 2010 Nov; 38(11):1047-57. PubMed ID: 20727381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic clinicopathologic factors, including immunologic expression in diffuse large B-cell lymphomas.
    Zhang A; Ohshima K; Sato K; Kanda M; Suzumiya J; Shimazaki K; Kawasaki C; Kikuchi M
    Pathol Int; 1999 Dec; 49(12):1043-52. PubMed ID: 10632924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.